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Breast cancer mortality rates are levelling off or beginning to decline in
many western countries: analysis of time trends, age-cohort and age-
period models of breast cancer mortality in 20 countries
C Hermon' and V Berall
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Summary Age-standardised mortality rates for breast cancer were examined for 20 countries in Europe,
North America, Australia and New Zealand from 1950 to 1992 and age-birth cohort and age-period ofdeath
models were fitted to the data. Breast cancer mortality rates generally increased in the earlier decades, but more
recently rates have levelled off or begun to decline in most countries. Only in 4 of the 20 countries studied,
Belgium, Hungary, Poland and Spain, was there no evidence of a decline or levelling off of mortality in recent
birth cohorts or in recent years. In the other countries the decline in mortality appeared to be in part due to
birth cohort effects and in part due to period effects. The birth cohort effects were suggestive of a decline in
breast cancer rates among women born after about 1920 and were evident in many countries especially
Canada, The Netherlands, The United Kingdom and the United States. The decline in mortality in women
born after 1920 appeared to be in part related to a reduction in childlessness and a reduction in age at first
birth in those generations. As well as the birth cohort effects, there was some evidence of a recent overall
decline in mortality rates in several countries, e.g. Austria, FRG, Greece and the UK, and this may be due to
an increase in survival resulting from improved management and treatment of women with breast cancer.
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period models
Although mortality from breast cancer has generally been
increasing worldwide, there have been recent reports of
declining mortality in the UK, USA, Norway, Sweden and
elsewhere (Blot et al., 1987; Tarone and Chu, 1992; Coleman
et al., 1993; Ursin et al., 1994; Beral et al., 1995, 1996).
In this paper we report on mortality trends in different
cohorts of women and different periods of time for 20
countries in Europe, North America, Australia and New
Zealand.
Methods
Information on age-specific numbers of deaths from breast
cancer and population data for 20 countries were obtained
from the World Health Organization's Division of Epide-
miological Surveillance and Health Situation and Trend
Assessment. Data were provided for each year during the
period 1950-92 in 5 year age groups. The countries were
selected on the basis that data were available for at least the
period 1960-90.
During the period 1950-92 the coding of cause of death
spanned the sixth to the ninth revision of the International
Classification of Disease (ICD). Breast cancer mortality data
used for this analysis were coded using the Basic Tabulation
list of the ICD, according to the following codes: [ICD 6 and
7: A051 (WHO, 1949; WHO, 1957), ICD 8: A054 (WHO,
1967), ICD 9: B113 (WHO, 1977)].
Data were initially displayed using mortality rates at ages
30-79 age standardised against the world standard (Parkin et
al., 1992) for the individual years that were available. Age,
cohort of birth and period of death are not statistically
independent, because when two are defined the third is
automatically implied and attempts to model all three factors
can lead to over parameterisation (Breslow and Day, 1987).
In these analyses two separate models were derived for each
country: an age-birth cohort and an age-period of death
model. Log-linear Poisson models (Clayton and Schiffiers,
1987) were constructed using the statistical package EGRET
(Statistics and Epidemiology Research Corporation, 1985).
For the birth cohort models 16 birth cohorts were derived
based on year and age at death (e.g. women aged 30-34 who
died in 1955-59 belong to the 1920-30 birth cohort). Each
birth cohort spans a 10-year interval and is subsequently
described by its central year (e.g. 1925). The earliest birth
cohorts only include women in the oldest age groups whereas
the most recent birth cohorts only include women in the
youngest age groups. For the age-period of death modelling
eight 5 year calendar periods were used from 1950-89, plus
for the most recent period (1990-92) a 3 year period was
used. For a few countries data were only available up to
1991.
In fitting the data, the arbitrary reference category used
for the age-birth cohort model was the 1920 birth cohort
whereas for the age-period of death model the 1950-54
calendar period was used. The parameter estimates produced
by the age-cohort modelling are cohort-specific mortality
ratios while the estimates produced by the age-period
modelling are period-specific mortality ratios. Both sets of
ratios are comparable to a relative risk estimate and can be
interpreted in a similar manner.
Results
Mortality trends
Age-standardised mortality data are displayed for the 20
countries in alphabetical order in Figure 1. All rates are
standardised to the same population and so the rates are
directly comparable. In most countries there has been an
overall increase in rates over the first four decades for which
data were presented. However, more recently in some
countries the rates have levelled off or decreased, e.g.
Austria, FRG, The Netherlands and the UK. For some
countries the rates have been relatively constant throughout,
including Australia, Canada and the USA.
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Cohort patterns
The results of age-cohort modelling ofthe mortality data for
different countries are presented alphabetically in Figure 2.
Until the recent birth cohorts mortality increased in
successive generations of women in most countries. In
several countries, e.g. Canada, The Netherlands, Switzer-
land, the UK and the USA, there has been a downturn in
cohort mortality ratios for recent birth cohorts. The
downturn started at around the 1920 birth cohort for most
of these countries and the mortality ratios have continued to
fall in subsequent birth cohorts. Sweden has also shown a
downward trend in cohort mortality ratios which has been
apparent since the 1910 birth cohort.
Australia has experienced stable cohort mortality ratios
for all birth cohorts examined. In France and Italy the cohort
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mortality ratios increased markedly for cohorts born up to
about 1920 but the rate of increase has slowed down since
then. For other countries, e.g. Greece, Hungary and Poland,
the cohort mortality ratios have generally been increasing
throughout the study period. The cohort patterns for
Denmark, Finland, New Zealand and Norway are difficult
to interpret, as the ratios fluctuate due to the small
populations of these countries (each has a female population
of less than 3 million). Nevertheless, Denmark and Norway
show some evidence of a downturn in cohort mortality ratios
amongst recent birth cohorts.
Period trends
The results from the age-period of death modelling are
shown in Figure 3. Several countries, e.g. Austria, Canada,
Greece, Sweden and the UK, show a levelling off or decline
of ratios in recent years where previously they were
increasing.
Several other countries, e.g. Australia, The Netherlands,
Switzerland and the USA, have experienced fairly uniform
ratios throughout the period. For some other countries, e.g.
Belgium, France, Hungary, Italy, Poland and Spain, the
1.6 Australia .. . Austria , .- Belgium 1.6 Canada
1.4 1.4 1.4 1.4
1.2 I1.2 I1.2 1.2
1.0 1.0 1.0 1.0
0.8 0.6 0.6
0.6 -0.6 0.64 0.6
0.4 O 0.4 0.4
0.2 0.2 0.2 0.2##
0 0 0 0
,6 ' Denmark 1. Finland ' France |. FRG
1.4 1.4 1.4 1.4
1.2 1.2 1.212
1.0 1.0 1.0 1.0
0.8 ~~~~~~~~~~~~~~0.6 0.8 0.8
0.6 0.6 0.6 0.64
0.4 0.4 0.4 0.4I
0.2 0.2 0.2 0.2I
0 0 0 0
1.6 1.6 1.8- Greece 1.6 Hungary 1A Italy 1.4 Netherlands
1.4 I1.4
1.2 1.2 ~~~~~~~~~~~~~~~1.2 1.2
1.0 1.0
1.0 1.0-
0.6 0.6 .60.
0.6 0.6 0.6 ~~0.6
0.4o 0.4 .O4
0.2 0.2 0.2 0.2
0 0 0 t0
1.6 16 1.6 1.0
1.4 IeNew Zealand 1| IA Norway 1.4 IiPoland 1.6 n Spain
1.2 ~ * 1.2 1.2 1.4
1.0 1.0 1.0 1 t.2
0.6 0.6 0.6 1.0
0.6 0.6 I0.6 I0.8
0.6
OR0.4 OR 0.4
1:
0.2 0.2 0.2 .02
0 0 0 0 O~~~~~~~~~~~~~~~~~~~~~loIII loIIOI.lllllll
1E 1. 1. 1.61| a q E | 3 E f 2 i 1 s | 1
1ig Sweden moa It Switzerland 1ri Iy United Kingdom 1.4 i United States
1.2 1.2 t1.2 1.2
1.0 1.0 1.0 -1.0
0.6 . . 0.6
0.6 0.6 0.6 I0.6
0.4 0.4 0.4 I0.4
0.2 0.2 0.2 0.2
0 0 ~~~~~~~~~~~~~~0 0
Figure 2 Cohort-specific mortality ratios of breast cancer mortality for women aged 30-79 for cohorts with a central year of birth
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period mortality ratios are increasing. Trends for Denmark, women childless by age 40 for cohorts born in 1930, 1935,
Finland, Norway and New Zealand are difficult to assess 1940 and 1945 for 11 countries. Data for earlier birth cohorts
because of small numbers but rates appear to have remained and for other countries were not available. Of the countries
steady or declined. which showed a recent fall in breast cancer mortality for
cohorts born after around 1920, data could be found for
England and Wales, The Netherlands, Norway, Sweden and
Switzerland, and all except Switzerland experienced a
To explain the observed patterns in breast cancer mortality in downward trend in the percentage of women who were
different birth cohorts of women, data on reproductive childless by age 40 for cohorts born after 1930. However, in
factors in successive generations of women were sought, but two countries which showed no fall in cohort mortality
only limited data were available (Council of Europe, 1990; ratios, Belgium and Spain, the percentage of women childless
Coleman et al., 1993). Table I shows the percentage of had also decreased. Only in one country (FRG) has there
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been an increase in the percentage of women childless by age
40 in recent cohorts, and in that country there was no recent
downturn trend in birth cohort mortality ratios.
Data on mean age at first childbirth are presented in Table
II. Unfortunately, this type of data was available for only six
countries and for cohorts born in 1930 or later. These six
countries all show a decline in age at first childbirth amongst
women born from 1930 to 1945. For some countries
(England and Wales, The Netherlands and Switzerland) the
decrease in mean age at first childbirth parallels the fall in
cohort-specific breast cancer rates. In the remaining three
countries (Austria, France and FRG), while age at first birth
is declining there is no parallel fall in cohort breast cancer
mortality.
Table III shows the completed family size data for the
1930 to 1945 birth cohorts. All the countries that in our
Table 1 Percentage of women childless by age 40 by birth cohort
(Coleman et al., 1993)
Mid-year ofbirth
Country 1930 1935 1940 1945
Austria 17.2 14.8 14.3 15.1
Belgium 16.8 14.8 13.1 12.8
England and Wales 13.8 11.4 11.1 10.2
France 13.0 10.5 8.3 8.1
FRG ND 9.2 10.6 12.7
Italy ND 15.5 12.6 11.6
Netherlands 15.4 11.7 11.9 11.7
Norway ND 9.6 9.5 9.2
Spaina 14.2 12.0 11.0 10.0
Sweden 14.7 13.4 13.2 12.9
Switzerland ND 18.6 13.9 17.6
aData were available for the following birth cohorts 1933, 1938,
1943 and 1948. ND, no data.
Table II Mean age at first childbirth within wedlock by birth
cohort (Council of Europe, 1990)
Mid-year ofbirth
Country 1930 1935 1940 1945
Austria 25.5 24.8 24.2 23.7
England and Wales 25.2 24.7 24.1 24.2
France 24.8 24.8 24.4 24.1
FRG 25.5 25.2 24.6 24.0
Netherlands 26.0 25.5 25.0 24.5
Switzerland 26.5 26.0 25.3 25.2
Table m Completed family size (Council of Europe, 1990)
Mid-year ofbirth
Country 1930 1935 1940 1945
Austria 2.32 2.45 2.13 1.94
Belgium 2.29 2.27 2.17 1.94
Canadaa 3.37 3.16 2.72 ND
Denmark 2.36 2.38 2.24 2.06
England and Wales 2.35 2.41 2.36 2.17
France 2.64 2.58 2.41 2.22
FRG 2.14 2.17 1.97 1.77
Greeceb 2.21 2.02 2.01 2.00
Italy 2.30 2.28 2.15 2.08
Netherlands 2.67 2.49 2.22 1.99
Norway 2.49 2.57 2.45 2.21
Spain 2.59 2.67 2.59 2.43
Sweden 2.11 2.14 2.05 1.96
Switzerland 2.18 2.19 2.09 1.85
United Statesa 3.06 3.06 2.68 ND
a Data were provided by Coleman. bData were available for the
following birth cohorts 1931, 1936, 1941 and 1946. ND, no data.
analyses showed a recent downturn in birth cohort mortality
ratios also experienced a reduction in the completed cohort
fertility for the same birth cohorts.
Discussion
The main finding from this analysis is that, although breast
cancer rates had been increasing in most Western countries
since 1950, recently mortality rates seem to have levelled off
or begun to decline in many of them. In Australia, Austria,
Canada, FRG, Greece, The Netherlands, Sweden, Switzer-
land, the USA and the UK mortality rates are either constant
or have recently levelled off or have begun to decline. The
decline appears to be in part due to birth cohort effects and
in part due to period effects although it is sometimes difficult
to separate these effects using mathematical models. The
cohort effects are strongest in Canada, The Netherlands,
Sweden, Switzerland, the UK and the USA where cohort
mortality ratios have declined for women born after about
1920. In France and Italy breast cancer mortality rates are
still increasing, but the rate of increase has slowed down for
cohorts born since around 1920. Only in Belgium, Hungary,
Poland and Spain have the rates continued to increase
throughout the period studied and for all birth cohorts.
There is suggestive evidence of a decline in Denmark,
Finland, Norway and New Zealand but the population of
each country is small and the rates are unstable. These results
extend and support the conclusions of others, based on data
from earlier years, that breast cancer mortality rates may be
declining in many Western countries (Blot et al., 1987;
Coleman et al., 1993; Beral et al., 1996).
Several factors might influence the breast cancer mortality
rates: change in death certification coding practices; change in
incidence rates due to changes in risk factors; and changes in
survival due to improvements in treatment and/or earlier
diagnoses. Apparent increases or decreases in breast cancer
mortality can result from changes in death certification. In all
countries included here diseases are classified according to the
World Health Organization's International Classification of
Disease (ICD) which has not changed for breast cancer over
the years of study. In three countries there have been some
minor changes in the interpretation of the WHO rules, which
mainly affect older women. In Britain, the interpretation of
the ICD coding rule was revised in 1984, which resulted in an
artefactual increase in breast cancer mortality, mostly in the
oldest age groups (OPCS, 1984). In Sweden, additional rules
were instituted by the National Central Bureau of Statistics
(1983) in 1981 for cause of death coding which produced an
artificial lowering of mortality, the effect being strongest
amongst the older age groups. In Denmark changes in coding
were introduced in 1966 when information from autopsies
was included on the death certificate (Ewertz and Carstensen,
1988), consequently, a decline in breast cancer mortality
occurred in the oldest age groups due to other more common
causes of death being coded. We are unaware of any other
changes in cause of death coding that may affect these results.
In limiting our analyses to women aged 30-79 the effect of
these changes in coding practices should be minimised.
Changes in cohort mortality ratios may be in part due to
changes in childbearing patterns (childlessness, parity, age at
first full-term pregnancy) for different birth cohorts of
women. Blot et al. (1987) and Tarone and Chu (1992)
reported on the decrease in US breast cancer risk with
successive birth cohorts beginning around 1925 and
demonstrated how age-specific breast cancer mortality rates
parallel changes in childbearing practices, e.g. for women
aged 40-59, the decline in breast cancer mortality has been
linked to increased fertility during the post-war years. This
also appears to have happened in the UK with the average
age at first birth and proportion of women childless declining
after the second world war (Beral et al., 1996).
It was not possible to obtain data on reproductive factors
for all the countries described here. In countries for which
data are available there has been a general reduction in the
959
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percentage of women childless by age 40 and mean age at
first birth between the 1930 and 1945 birth cohorts, and in
these countries mortality rates have levelled off or begun to
decrease. The only clear exceptions are Belgium and Spain
where the percentage of women childless has declined for
cohorts born after 1930 but breast cancer rates are increasing.
In France and Italy the results are equivocal as the
percentage of childless women and the mean age at first
childbirth in France has declined (data for Italy were not
available) and yet breast cancer mortality rates are still rising,
although less rapidly than before. There appears to be little
correlation between cohort-specific breast cancer ratios and
average family size. This is possibly because ever having had
a child and an early age at first childbirth are stronger risk
factors for breast cancer than total number of children
(Kelsey et al., 1993).
Countries which have shown a recent downturn in
mortality are generally the ones which have the highest
breast cancer mortality rates, e.g. The Netherlands and the
UK, whereas those countries with the lowest breast cancer
mortality rates tend to be the ones in which mortality has
been increasing, e.g. Poland and Spain. It is possible that
what is occurring is a converging of rates to a more common
level. This may reflect an international convergence of
fertility levels. The prevalence of past oral contraceptive use
is increasing among generations of women born since 1930 in
Sweden, the UK and the USA (Beral et al., 1996) and in
many other Western countries and it is in those birth cohorts
that breast cancer rates are declining.
Improvements in survival can also affect mortality trends.
The EUROCARE Study has reported on cancer survival in
Europe (Berrino et al., 1995). Data are presented for breast
cancer for 10 of the 16 European countries included in these
analyses. A slight improvement or no change in relative 5
year survival for the period 1983-85 compared with 1978-
80 was apparent for nine countries (Denmark, England,
Finland, France, FRG, Italy, The Netherlands, Poland and
Switzerland). In all except Poland the improvement in
survival has been accompanied by stabilising or a decline in
mortality rates. In Spain there has been no improvement in
relative survival reported by Berrino et al. (1995) and this
supports the data presented here of increasing mortality
during the study period.
Increased survival can be achieved by early detection of
tumours and effective treatment. Blot et al. (1987) concluded
that for women aged less than 40, recent changes in the
detection and management of breast cancer have contributed
to a reduced mortality in young women in the United States.
National policies to promote mammography screening have
been established over the last two decades in some countries,
although in most countries national screening programmes
have only recently been introduced and therefore it is too
early for any effect to be seen in mortality rates. Widespread
use of adjuvant chemotherapy during the 1980s has been
shown to be an effective treatment for breast cancer (Early
Breast Cancer Trialists Collaborative Group, 1992). It would
seem that early effective treatment may be playing a part in
the recent decline in mortality in England and Wales (Beral et
al., 1995; Baum, 1995) and perhaps elsewhere; but the effects
of such treatment are very recent.
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